6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
27m ago	TDG Gold Appoints Paul Geddes as Senior Vice-President Business Development and Strategy
27m ago	Meryllion Resources Announces New Non-Brokered LIFE Financing
27m ago	Mkango Resources Announces Opening of Hypromag Plant in Pforzheim
27m ago	Aurania Resources Enters into Agreement with St-Georges to Jointly Advance the Thor Epithermal Gold Project in Iceland
27m ago	Eskay Mining Establishes Rapid Turnaround Analytical Laboratory in Stewart, BC to Accelerate Gold Discovery using detectORE(TM) Technology

About

Ocugen Inc (NASDAQ:OCGN) — investor relations, events, news, and company updates on 6ix.

Latest News

Ocugen to Present at April 2026 Investor and Industry Conferences

Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease

Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa Clinical Trial Evaluating OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Ocugen to Host Webcast on Tuesday, March 24 at 8 a.m. EDT to Discuss Phase 2 Clinical Trial Data for OCU410—Modifier Gene Therapy for Geographic Atrophy

Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results

Financials

Revenue

$4.41 M

Market Cap

$586.94 M

EPS

-0.23

Community Chat

Ask AI